BusinessAddex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy by jkslogan19@gmail.comJanuary 21, 2021028 Share0 Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy